MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on June 24, 2004; DOI: 10.1124/mol.104.002626


0026-895X/04/6603-667-674$20.00
Mol Pharmacol 66:667-674, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.002626v1
66/3/667    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakatani, K.
Right arrow Articles by Ohizumi, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakatani, K.
Right arrow Articles by Ohizumi, Y.

{gamma}-Mangostin Inhibits Inhibitor-{kappa}B Kinase Activity and Decreases Lipopolysaccharide-Induced Cyclooxygenase-2 Gene Expression in C6 Rat Glioma Cells

Keigo Nakatani1, Tohru Yamakuni, Nobuhiko Kondo, Tsutomu Arakawa, Kenji Oosawa, Susumu Shimura, Hiroyasu Inoue, and Yasushi Ohizumi

Department of Pharmaceutical Molecular Biology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan (K.N., T.Y., N.K., Y.O.); Central Laboratory, Lotte Co., Ltd., Saitama, Japan (T.A., K.O., S.S.); and Department of Pharmacology, National Cardiovascular Center Research Institute, Osaka, Japan (H.I.)

We investigated the effect of {gamma}-mangostin purified from the fruit hull of the medicinal plant Garcinia mangostana on spontaneous prostaglandin E2 (PGE2) genase release and inducible cyclooxy-2 (COX-2) gene expression in C6 rat glioma cells. An 18-h treatment with {gamma}-mangostin potently inhibited spontaneous PGE2 release in a concentration-dependent manner with the IC50 value of approximately 2 µM, without affecting the cell viability even at 30 µM. By immunoblotting and reverse-transcription polymerase chain reaction, we showed that {gamma}-mangostin concentration-dependently inhibited lipopolysaccharide (LPS)-induced expression of COX-2 protein and its mRNA, but not those of constitutive COX-1 cyclooxygenase. Because LPS is known to stimulate inhibitor {kappa}B (I{kappa}B) kinase (IKK)-mediated phosphorylation of I{kappa}B followed by its degradation, which in turn induces nuclear factor (NF)-{kappa}B nuclear translocation leading to transcriptional activation of COX-2 gene, the effect of {gamma}-mangostin on the IKK/I{kappa}B cascade controlling the NF-{kappa}B activation was examined. An in vitro IKK assay using IKK protein immunoprecipitated from C6 cell extract showed that this compound inhibited IKK activity in a concentration-dependent manner, with the IC50 value of approximately 10 µM. Consistently {gamma}-mangostin was also observed to decrease the LPS-induced I{kappa}B degradation and phosphorylation in a concentration-dependent manner, as assayed by immunoblotting. Furthermore, luciferase reporter assays showed that {gamma}-mangostin reduced the LPS-inducible activation of NF-{kappa}B–and human COX-2 gene promoter region-dependent transcription. {gamma}-Mangostin also inhibited rat carrageenan-induced paw edema. These results suggest that {gamma}-mangostin directly inhibits IKK activity and thereby prevents COX-2 gene transcription, an NF-{kappa}B target gene, probably to decrease the inflammatory agent-stimulated PGE2 production in vivo, and is a new useful lead compound for anti-inflammatory drug development.


Received May 11, 2004; accepted June 18, 2004

Address correspondence to: Dr. Tohru Yamakuni, Department of Pharmaceutical Molecular Biology, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba, Aramaki, Aoba-ku, Sendai 980-8578, Japan. E-mail: yamakuni{at}mail.pharm.tohoku.ac.jp




This article has been cited by other articles:


Home page
J. Nutr.Home page
A. Bumrungpert, R. W. Kalpravidh, C. Chitchumroonchokchai, C.-C. Chuang, T. West, A. Kennedy, and M. McIntosh
Xanthones from Mangosteen Prevent Lipopolysaccharide-Mediated Inflammation and Insulin Resistance in Primary Cultures of Human Adipocytes
J. Nutr., June 1, 2009; 139(6): 1185 - 1191.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. Yamini, X. Yu, P. Pytel, N. Galanopoulos, V. Rawlani, J. Veerapong, K. Bickenbach, and R. R. Weichselbaum
Adenovirally Delivered Tumor Necrosis Factor-{alpha} Improves the Antiglioma Efficacy of Concomitant Radiation and Temozolomide Therapy
Clin. Cancer Res., October 15, 2007; 13(20): 6217 - 6223.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
M. Kitazawa, Y. Shibata, S. Hashimoto, Y. Ohizumi, and T. Yamakuni
Proinsulin C-Peptide Stimulates a PKC/I{kappa}B/NF-{kappa}B Signaling Pathway to Activate COX-2 Gene Transcription in Swiss 3T3 Fibroblasts
J. Biochem., June 1, 2006; 139(6): 1083 - 1088.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
E. Fosslien
Cardiovascular Complications of Non-Steroidal Anti-Inflammatory Drugs
Ann. Clin. Lab. Sci., October 1, 2005; 35(4): 347 - 385.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics